Calcium in PDB 8rmy: Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
Enzymatic activity of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
All present enzymatic activity of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02:
2.3.2.13;
Protein crystallography data
The structure of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02, PDB code: 8rmy
was solved by
J.E.Heggelund,
L.M.Sollid,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
69.20 /
2.90
|
Space group
|
I 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
94.184,
260.191,
139.024,
90,
95.1,
90
|
R / Rfree (%)
|
19.5 /
24.3
|
Calcium Binding Sites:
The binding sites of Calcium atom in the Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
(pdb code 8rmy). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the
Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02, PDB code: 8rmy:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
Calcium binding site 1 out
of 6 in 8rmy
Go back to
Calcium Binding Sites List in 8rmy
Calcium binding site 1 out
of 6 in the Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca503
b:89.9
occ:1.00
|
OD1
|
A:ASN225
|
2.2
|
103.6
|
1.0
|
O
|
A:ASN225
|
2.3
|
92.0
|
1.0
|
O
|
A:ASN227
|
2.3
|
122.1
|
1.0
|
O
|
A:ALA222
|
2.4
|
91.0
|
1.0
|
OD1
|
A:ASP229
|
2.4
|
93.2
|
1.0
|
O
|
A:HOH604
|
2.6
|
61.8
|
1.0
|
OD2
|
A:ASP229
|
2.7
|
90.5
|
1.0
|
CG
|
A:ASP229
|
2.9
|
91.3
|
1.0
|
CG
|
A:ASN225
|
3.2
|
91.7
|
1.0
|
C
|
A:ASN225
|
3.2
|
102.1
|
1.0
|
C
|
A:ASN227
|
3.4
|
106.4
|
1.0
|
C
|
A:ALA222
|
3.4
|
90.2
|
1.0
|
N
|
A:ASN227
|
3.6
|
88.4
|
1.0
|
C
|
A:SER226
|
3.8
|
90.9
|
1.0
|
ND2
|
A:ASN225
|
3.9
|
111.9
|
1.0
|
CA
|
A:ASN227
|
4.0
|
103.8
|
1.0
|
CA
|
A:ASN225
|
4.0
|
98.8
|
1.0
|
O
|
A:SER226
|
4.1
|
90.1
|
1.0
|
N
|
A:SER226
|
4.1
|
108.1
|
1.0
|
CB
|
A:ASN225
|
4.2
|
95.0
|
1.0
|
N
|
A:ASN225
|
4.2
|
76.8
|
1.0
|
CA
|
A:ALA222
|
4.2
|
85.8
|
1.0
|
CB
|
A:ASP229
|
4.3
|
118.4
|
1.0
|
N
|
A:MET223
|
4.3
|
71.6
|
1.0
|
CA
|
A:MET223
|
4.3
|
78.6
|
1.0
|
CB
|
A:ASN227
|
4.4
|
88.9
|
1.0
|
O
|
A:PHE365
|
4.4
|
88.1
|
1.0
|
CA
|
A:SER226
|
4.5
|
97.7
|
1.0
|
N
|
A:ASP229
|
4.5
|
72.6
|
1.0
|
N
|
A:ASP228
|
4.6
|
101.8
|
1.0
|
OD2
|
A:ASP228
|
4.6
|
156.3
|
1.0
|
CB
|
A:ALA222
|
4.6
|
71.1
|
1.0
|
C
|
A:MET223
|
4.7
|
76.6
|
1.0
|
CB
|
A:ASP228
|
4.7
|
106.3
|
1.0
|
N
|
A:GLY231
|
4.8
|
103.7
|
1.0
|
CG
|
A:ASP228
|
4.9
|
115.8
|
1.0
|
CA
|
A:ASP229
|
4.9
|
83.2
|
1.0
|
CA
|
A:GLY231
|
4.9
|
105.9
|
1.0
|
|
Calcium binding site 2 out
of 6 in 8rmy
Go back to
Calcium Binding Sites List in 8rmy
Calcium binding site 2 out
of 6 in the Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca504
b:76.0
occ:1.00
|
OD1
|
A:ASN394
|
2.2
|
76.2
|
1.0
|
O
|
A:HOH606
|
2.2
|
72.9
|
1.0
|
O
|
A:SER416
|
2.3
|
84.1
|
1.0
|
OE2
|
A:GLU449
|
2.4
|
73.8
|
1.0
|
OE2
|
A:GLU444
|
2.7
|
80.5
|
1.0
|
OE1
|
A:GLU444
|
2.8
|
75.2
|
1.0
|
CD
|
A:GLU444
|
3.1
|
96.5
|
1.0
|
CG
|
A:ASN394
|
3.3
|
112.7
|
1.0
|
C
|
A:SER416
|
3.5
|
92.8
|
1.0
|
CD
|
A:GLU449
|
3.6
|
100.3
|
1.0
|
NH2
|
A:ARG450
|
3.7
|
104.7
|
1.0
|
ND2
|
A:ASN394
|
3.9
|
112.1
|
1.0
|
O
|
A:ASN394
|
4.1
|
98.7
|
1.0
|
OD1
|
A:ASP396
|
4.2
|
118.7
|
1.0
|
N
|
A:HIS417
|
4.3
|
84.7
|
1.0
|
OE1
|
A:GLU449
|
4.3
|
100.0
|
1.0
|
O
|
A:ALA395
|
4.3
|
129.9
|
1.0
|
CA
|
A:HIS417
|
4.3
|
97.2
|
1.0
|
CA
|
A:SER416
|
4.4
|
99.5
|
1.0
|
CA
|
A:ASN394
|
4.4
|
85.3
|
1.0
|
CB
|
A:ASN394
|
4.5
|
93.3
|
1.0
|
C
|
A:ASN394
|
4.5
|
89.3
|
1.0
|
CG
|
A:GLU449
|
4.6
|
102.7
|
1.0
|
NZ
|
A:LYS441
|
4.7
|
74.5
|
1.0
|
CG
|
A:GLU444
|
4.7
|
95.0
|
1.0
|
CB
|
A:SER416
|
4.7
|
89.5
|
1.0
|
CZ
|
A:ARG450
|
4.8
|
87.7
|
1.0
|
|
Calcium binding site 3 out
of 6 in 8rmy
Go back to
Calcium Binding Sites List in 8rmy
Calcium binding site 3 out
of 6 in the Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca505
b:84.3
occ:1.00
|
OD2
|
A:ASP310
|
2.3
|
101.2
|
1.0
|
O
|
A:SER308
|
2.3
|
102.6
|
1.0
|
OD2
|
A:ASP325
|
2.4
|
87.0
|
1.0
|
OD1
|
A:ASN306
|
2.4
|
73.8
|
1.0
|
OD1
|
A:ASP304
|
2.4
|
118.6
|
1.0
|
OD1
|
A:ASP302
|
2.5
|
108.0
|
1.0
|
CG
|
A:ASN306
|
3.1
|
86.8
|
1.0
|
ND2
|
A:ASN306
|
3.1
|
87.3
|
1.0
|
CG
|
A:ASP325
|
3.1
|
90.8
|
1.0
|
OD1
|
A:ASP325
|
3.2
|
94.4
|
1.0
|
CG
|
A:ASP304
|
3.3
|
96.8
|
1.0
|
CG
|
A:ASP302
|
3.4
|
87.4
|
1.0
|
CG
|
A:ASP310
|
3.4
|
85.1
|
1.0
|
C
|
A:SER308
|
3.5
|
76.5
|
1.0
|
OD2
|
A:ASP304
|
3.7
|
104.6
|
1.0
|
OD2
|
A:ASP302
|
3.8
|
70.6
|
1.0
|
OD1
|
A:ASP310
|
4.0
|
89.3
|
1.0
|
N
|
A:SER308
|
4.3
|
76.1
|
1.0
|
OG
|
A:SER308
|
4.3
|
88.3
|
1.0
|
N
|
A:ASP310
|
4.3
|
108.8
|
1.0
|
CA
|
A:SER308
|
4.3
|
86.8
|
1.0
|
N
|
A:VAL309
|
4.4
|
71.1
|
1.0
|
CB
|
A:ASP310
|
4.4
|
80.0
|
1.0
|
CA
|
A:VAL309
|
4.5
|
83.5
|
1.0
|
CB
|
A:ASP302
|
4.5
|
85.6
|
1.0
|
CB
|
A:ASN306
|
4.5
|
85.1
|
1.0
|
CB
|
A:ASP325
|
4.6
|
79.5
|
1.0
|
CB
|
A:ASP304
|
4.6
|
91.1
|
1.0
|
N
|
A:ASP304
|
4.7
|
92.6
|
1.0
|
CB
|
A:SER308
|
4.7
|
79.7
|
1.0
|
N
|
A:ASN306
|
4.8
|
81.1
|
1.0
|
N
|
A:THR303
|
4.8
|
112.1
|
1.0
|
C
|
A:VAL309
|
4.9
|
104.0
|
1.0
|
C
|
A:ASP304
|
4.9
|
89.9
|
1.0
|
CA
|
A:ASP302
|
4.9
|
87.4
|
1.0
|
CA
|
A:ASP304
|
5.0
|
96.5
|
1.0
|
|
Calcium binding site 4 out
of 6 in 8rmy
Go back to
Calcium Binding Sites List in 8rmy
Calcium binding site 4 out
of 6 in the Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Ca502
b:96.8
occ:1.00
|
OD1
|
D:ASN225
|
2.2
|
105.8
|
1.0
|
O
|
D:ALA222
|
2.3
|
92.7
|
1.0
|
O
|
D:ASN227
|
2.3
|
104.1
|
1.0
|
O
|
D:ASN225
|
2.4
|
91.0
|
1.0
|
OD1
|
D:ASP229
|
2.6
|
81.1
|
1.0
|
OD2
|
D:ASP229
|
2.7
|
88.1
|
1.0
|
CG
|
D:ASP229
|
2.9
|
85.7
|
1.0
|
CG
|
D:ASN225
|
3.1
|
96.8
|
1.0
|
C
|
D:ALA222
|
3.3
|
101.4
|
1.0
|
C
|
D:ASN225
|
3.4
|
97.5
|
1.0
|
C
|
D:ASN227
|
3.4
|
105.8
|
1.0
|
N
|
D:ASN227
|
3.7
|
85.7
|
1.0
|
ND2
|
D:ASN225
|
3.8
|
103.5
|
1.0
|
C
|
D:SER226
|
4.0
|
93.6
|
1.0
|
CA
|
D:ASN227
|
4.0
|
84.1
|
1.0
|
CA
|
D:ALA222
|
4.1
|
97.8
|
1.0
|
CA
|
D:ASN225
|
4.1
|
88.7
|
1.0
|
CB
|
D:ASN225
|
4.2
|
89.4
|
1.0
|
O
|
D:PHE365
|
4.3
|
85.0
|
1.0
|
N
|
D:ASN225
|
4.3
|
90.1
|
1.0
|
N
|
D:SER226
|
4.3
|
88.1
|
1.0
|
O
|
D:SER226
|
4.3
|
101.5
|
1.0
|
N
|
D:MET223
|
4.3
|
95.2
|
1.0
|
OD2
|
D:ASP228
|
4.3
|
117.8
|
1.0
|
CB
|
D:ASN227
|
4.3
|
91.3
|
1.0
|
CB
|
D:ASP229
|
4.4
|
90.7
|
1.0
|
CA
|
D:MET223
|
4.4
|
84.8
|
1.0
|
CB
|
D:ALA222
|
4.5
|
93.2
|
1.0
|
CB
|
D:ASP228
|
4.5
|
82.2
|
1.0
|
N
|
D:ASP229
|
4.6
|
94.6
|
1.0
|
N
|
D:ASP228
|
4.6
|
77.2
|
1.0
|
CA
|
D:SER226
|
4.6
|
82.1
|
1.0
|
CG
|
D:ASP228
|
4.7
|
106.7
|
1.0
|
C
|
D:MET223
|
4.8
|
91.7
|
1.0
|
CA
|
D:ASP228
|
5.0
|
85.9
|
1.0
|
|
Calcium binding site 5 out
of 6 in 8rmy
Go back to
Calcium Binding Sites List in 8rmy
Calcium binding site 5 out
of 6 in the Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Ca503
b:93.9
occ:1.00
|
OD1
|
D:ASN394
|
2.2
|
87.8
|
1.0
|
O
|
D:HOH607
|
2.3
|
108.2
|
1.0
|
O
|
D:SER416
|
2.4
|
105.0
|
1.0
|
OE2
|
D:GLU449
|
2.5
|
76.2
|
1.0
|
OE2
|
D:GLU444
|
2.6
|
96.5
|
1.0
|
OE1
|
D:GLU444
|
2.8
|
90.8
|
1.0
|
CD
|
D:GLU444
|
3.1
|
112.7
|
1.0
|
CG
|
D:ASN394
|
3.3
|
83.5
|
1.0
|
C
|
D:SER416
|
3.5
|
107.5
|
1.0
|
CD
|
D:GLU449
|
3.6
|
95.3
|
1.0
|
NH2
|
D:ARG450
|
3.8
|
126.1
|
1.0
|
ND2
|
D:ASN394
|
4.0
|
98.2
|
1.0
|
OD1
|
D:ASP396
|
4.1
|
142.2
|
1.0
|
O
|
D:ASN394
|
4.1
|
89.8
|
1.0
|
OE1
|
D:GLU449
|
4.3
|
94.4
|
1.0
|
O
|
D:HOH604
|
4.3
|
76.3
|
1.0
|
CA
|
D:HIS417
|
4.3
|
116.9
|
1.0
|
N
|
D:HIS417
|
4.4
|
118.8
|
1.0
|
CA
|
D:ASN394
|
4.4
|
87.1
|
1.0
|
CB
|
D:ASN394
|
4.4
|
80.5
|
1.0
|
O
|
D:ALA395
|
4.5
|
102.4
|
1.0
|
CA
|
D:SER416
|
4.5
|
104.0
|
1.0
|
C
|
D:ASN394
|
4.5
|
87.0
|
1.0
|
NZ
|
D:LYS441
|
4.5
|
83.9
|
1.0
|
CG
|
D:GLU449
|
4.6
|
114.1
|
1.0
|
CG
|
D:GLU444
|
4.6
|
112.0
|
1.0
|
CB
|
D:SER416
|
4.8
|
89.8
|
1.0
|
CZ
|
D:ARG450
|
4.8
|
96.9
|
1.0
|
O
|
D:ILE419
|
5.0
|
84.2
|
1.0
|
|
Calcium binding site 6 out
of 6 in 8rmy
Go back to
Calcium Binding Sites List in 8rmy
Calcium binding site 6 out
of 6 in the Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02
 Mono view
 Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Transglutaminase 3 in Complex with Inhibitor Z-Don and Dh Patient- Derived Fab DH63-A02 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Ca504
b:84.3
occ:1.00
|
OD2
|
D:ASP325
|
2.2
|
72.4
|
1.0
|
OD1
|
D:ASP302
|
2.3
|
90.1
|
1.0
|
O
|
D:SER308
|
2.4
|
112.9
|
1.0
|
OD1
|
D:ASP304
|
2.4
|
123.2
|
1.0
|
OD1
|
D:ASN306
|
2.5
|
71.7
|
1.0
|
OD2
|
D:ASP310
|
2.6
|
78.2
|
1.0
|
CG
|
D:ASP325
|
2.9
|
83.8
|
1.0
|
OD1
|
D:ASP325
|
3.0
|
109.2
|
1.0
|
CG
|
D:ASP302
|
3.2
|
85.0
|
1.0
|
CG
|
D:ASP304
|
3.2
|
93.4
|
1.0
|
CG
|
D:ASN306
|
3.3
|
71.3
|
1.0
|
ND2
|
D:ASN306
|
3.4
|
80.3
|
1.0
|
C
|
D:SER308
|
3.5
|
84.2
|
1.0
|
OD2
|
D:ASP304
|
3.6
|
84.9
|
1.0
|
CG
|
D:ASP310
|
3.7
|
82.3
|
1.0
|
OD2
|
D:ASP302
|
3.7
|
65.0
|
1.0
|
CB
|
D:ASP302
|
4.3
|
103.2
|
1.0
|
CB
|
D:ASP325
|
4.3
|
83.1
|
1.0
|
OD1
|
D:ASP310
|
4.4
|
64.6
|
1.0
|
N
|
D:SER308
|
4.4
|
72.7
|
1.0
|
N
|
D:VAL309
|
4.4
|
70.1
|
1.0
|
N
|
D:ASP310
|
4.4
|
93.3
|
1.0
|
CA
|
D:VAL309
|
4.5
|
76.1
|
1.0
|
CA
|
D:SER308
|
4.5
|
85.7
|
1.0
|
CB
|
D:ASP304
|
4.5
|
77.7
|
1.0
|
OG
|
D:SER308
|
4.5
|
88.5
|
1.0
|
N
|
D:THR303
|
4.5
|
111.8
|
1.0
|
N
|
D:ASP304
|
4.6
|
88.0
|
1.0
|
CB
|
D:ASP310
|
4.6
|
71.2
|
1.0
|
CA
|
D:ASP302
|
4.7
|
100.8
|
1.0
|
CB
|
D:ASN306
|
4.7
|
65.1
|
1.0
|
C
|
D:ASP304
|
4.9
|
69.2
|
1.0
|
N
|
D:ASN306
|
4.9
|
66.8
|
1.0
|
CA
|
D:ASP304
|
4.9
|
76.3
|
1.0
|
C
|
D:VAL309
|
4.9
|
88.1
|
1.0
|
CB
|
D:SER308
|
5.0
|
98.1
|
1.0
|
|
Reference:
R.Iversen,
J.E.Heggelund,
S.Das,
L.M.Sollid.
Enzyme-Activating B-Cell Receptors Boost Antigen Presentation to Pathogenic T Cells in Gluten-Sensitive Autoimmunity Nat Commun 2025.
ISSN: ESSN 2041-1723
DOI: 10.1038/S41467-025-57564-5
Page generated: Thu Jul 10 06:54:55 2025
|